Letter
Nature 439, 204-207 (12 January 2006) | doi:10.1038/nature04369; Received 29 July 2005; Accepted 24 October 2005; Published online 23 November 2005
Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6
Hans Häcker1,6, Vanessa Redecke2, Blagoy Blagoev4, Irina Kratchmarova4, Li-Chung Hsu1, Gang G. Wang3, Mark P. Kamps3, Eyal Raz2, Hermann Wagner5, Georg Häcker5, Matthias Mann4 and Michael Karin1
Toll-like receptors (TLRs) are activated by pathogen-associated molecular patterns to induce innate immune responses and production of pro-inflammatory cytokines, interferons and anti-inflammatory cytokines1. TLRs activate downstream effectors through adaptors that contain Toll/interleukin-1 receptor (TIR) domains2, but the mechanisms accounting for diversification of TLR effector functions are unclear. To dissect biochemically TLR signalling, we established a system for isolating signalling complexes assembled by dimerized adaptors. Using MyD88 as a prototypical adaptor, we identified TNF receptor-associated factor 3 (TRAF3) as a new component of TIR signalling complexes that is recruited along with TRAF6. Using myeloid cells from TRAF3- and TRAF6-deficient mice, we show that TRAF3 is essential for the induction of type I interferons (IFN) and the anti-inflammatory cytokine interleukin-10 (IL-10), but is dispensable for expression of pro-inflammatory cytokines. In fact, TRAF3-deficient cells overproduce pro-inflammatory cytokines owing to defective IL-10 production. Despite their structural similarity, the functions of TRAF3 and TRAF6 are largely distinct. TRAF3 is also recruited to the adaptor TRIF (Toll/IL-1 receptor domain-containing adaptor-inducing IFN-
) and is required for marshalling the protein kinase TBK1 (also called NAK) into TIR signalling complexes, thereby explaining its unique role in activation of the IFN response.
- Laboratory of Gene Regulation and Signal Transduction, Department of Pharmacology, School of Medicine,
- Department of Medicine, and
- Department of Pathology, University of California, San Diego, 9500 Gilman Drive, La Jolla, California 92093, USA
- Center for Experimental BioInformatics (CEBI), Department of Biochemistry and Molecular Biology, University of Southern Denmark, Campusvej 55, DK-5230 Odense M, Denmark
- Institute for Medical Microbiology, Immunology and Hygiene, Technische Universität München, Trogerstr. 9, D-81675 Munich, Germany
- †Present address: Department of Infectious Diseases, St Jude Children's Research Hospital, 332 North Lauderdale Street, Memphis, Tennessee 38105, USA
Correspondence to: Hans Häcker1,6 Correspondence and requests for materials should be addressed to H.H. (Email: Hans.Haecker@stjude.org).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
SIGIRR puts the brakes on Toll-like receptorsNature Immunology News and Views (01 Sep 2003)
DUBbing down innate immunityNature Immunology News and Views (01 Oct 2004)
See all 8 matches for News And ViewsRESEARCH
TRAM is specifically involved in the Toll-like receptor 4?mediated MyD88-independent signaling pathwayNature Immunology Article (01 Nov 2003)
TRIF?GEFH1?RhoB pathway is involved in MHCII expression on dendritic cells that is critical for CD4 T-cell activationThe EMBO Journal Article (06 Sep 2006)
See all 37 matches for Research
